Microcolin B is primarily studied for its potential in biomedical applications due to its unique biological activities. It has shown significant promise as an immunosuppressive agent, making it a candidate for research in organ transplantation and autoimmune diseases. Additionally, its cytotoxic properties are being explored for potential use in cancer therapy, particularly in targeting specific cancer cell lines. Researchers are also investigating its role as an antiviral agent, with studies focusing on its efficacy against certain viruses. Its ability to modulate immune responses and inhibit cell proliferation positions it as a valuable compound in the development of novel therapeutic drugs.